9 results
·
19ms
·
Sources: EU EUDAMED, US FDA
b-ONE® Bipolar Head
FDA 510(k)
FDA Class 2
·Orthopedic
RZ Medizintechnik GmbH
FDA UDI
RZ-Medizintechnik GmbH·04049197182423·Guyon-Bougies, acutely curved,
35.5 c...
NEXUS® BONESCALPEL® 25MM, BLUNT BLADE TUBESET
FDA Adverse Event
Malfunction
·MISONIX, INC.·Product code LFL·May 21, 2026
HVT 2.0
FDA 510(k)
FDA Class 2
·Anesthesiology
i-STAT Alinity System with i-STAT Sodium test
FDA 510(k)
FDA Class 2
·Clinical Chemistry
PUMP MMT-715RNAS PRDGM INS SK EN ML PR
FDA Adverse Event
Injury
·MEDTRONIC MINIMED·Product code LZG·December 2, 2008
CURLIN ADMINISTRATION SET
FDA Adverse Event
Malfunction
·MOOG MEDICAL DEVICES GROUP·Product code FRN·August 3, 2011
ONETOUCHPING GLUCOSEMGMTSYSTEM
FDA Adverse Event
Malfunction
·ANIMAS CORPORATION·Product code LZG·July 29, 2013
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014